Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA
Barbara King, Sofia Hassiotis, Tina Rozaklis, Helen Beard, Paul J. Trim, Marten F. Snel, John J. Hopwood, Kim M. Hemsley
Research output: Contribution to journal › Article › peer-review
14Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA'. Together they form a unique fingerprint.